S&P 500
6,000.36
+1.0%
+$61.06
DJI
42,762.87
+1.0%
+$443.13
NASDAQ
19,529.95
+1.2%
+$231.50
Bitcoin
105,435.00
+0.4%
+450.99
AAPL
$204.23
+1.8%
+$3.60
AMZN
$213.68
+2.8%
+$5.77
GOOG
$174.93
+3.0%
+$5.12
META
$698.00
+2.0%
+$13.38
MSFT
$470.38
+0.6%
+$2.70
NVDA
$141.76
+1.3%
+$1.77
TSLA
$295.66
+3.8%
+$10.96
Alex Dumortier, CFA
TMFAleph1
Alex Dumortier covers daily market activity from a contrarian, value-oriented perspective.
Recent Articles by Alex Dumortier, CFA
![14995888227_35fd9a316b_z[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200379%2F14995888227_35fd9a316b_z1.jpg&op=resize&w=165&h=104)
Mar 29, 2016
by Alex Dumortier, CFA
The Lesson of Theranos and Valeant: You're Investing in a Business, Not Prestige
Associations with prestigious organizations or figures are nice, but the stories of Valeant Pharmaceuticals International and Theranos prove they aren't enough -- investors must dig deeper.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.